[HTML][HTML] Serum sST2 levels predict severe exacerbation of asthma
M Watanabe, K Nakamoto, T Inui, M Sada, K Honda… - Respiratory …, 2018 - Springer
Background Neutrophilic inflammation is associated with poorly controlled asthma. Serum
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
Serum sST2 levels predict severe exacerbation of asthma.
M Watanabe, K Nakamoto, T Inui, M Sada… - Respiratory …, 2018 - europepmc.org
Background Neutrophilic inflammation is associated with poorly controlled asthma. Serum
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
Serum sST2 levels predict severe exacerbation of asthma
M Watanabe, K Nakamoto, T Inui, M Sada… - Respiratory …, 2018 - go.gale.com
Background Neutrophilic inflammation is associated with poorly controlled asthma. Serum
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
Serum sST2 levels predict severe exacerbation of asthma
M Watanabe, K Nakamoto, T Inui… - Respiratory …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Neutrophilic inflammation is associated with poorly controlled asthma. Serum
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
[HTML][HTML] Serum sST2 levels predict severe exacerbation of asthma
M Watanabe, K Nakamoto, T Inui… - Respiratory …, 2018 - respiratory-research.biomedcentral …
Neutrophilic inflammation is associated with poorly controlled asthma. Serum levels of sST2,
a soluble IL-33 receptor, increase in neutrophilic lung diseases. We hypothesized that high …
a soluble IL-33 receptor, increase in neutrophilic lung diseases. We hypothesized that high …
[HTML][HTML] Serum sST2 levels predict severe exacerbation of asthma
M Watanabe, K Nakamoto, T Inui, M Sada… - Respiratory …, 2018 - ncbi.nlm.nih.gov
Background Neutrophilic inflammation is associated with poorly controlled asthma. Serum
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
Serum sST2 levels predict severe exacerbation of asthma
M Watanabe, K Nakamoto, T Inui, M Sada… - Respiratory …, 2018 - search.proquest.com
Background Neutrophilic inflammation is associated with poorly controlled asthma. Serum
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
Serum sST2 levels predict severe exacerbation of asthma.
M Watanabe, K Nakamoto, T Inui, M Sada… - Respiratory …, 2018 - search.ebscohost.com
Abstract < bold> Background: </bold> Neutrophilic inflammation is associated with
poorly controlled asthma. Serum levels of sST2, a soluble IL-33 receptor, increase in …
poorly controlled asthma. Serum levels of sST2, a soluble IL-33 receptor, increase in …
[引用][C] Serum sST2 levels predict severe exacerbation of asthma
M Watanabe, K Nakamoto, T Inui, M Sada… - Respiratory …, 2018 - cir.nii.ac.jp
Serum sST2 levels predict severe exacerbation of asthma.
M Watanabe, K Nakamoto, T Inui, M Sada… - Respiratory …, 2018 - europepmc.org
Background Neutrophilic inflammation is associated with poorly controlled asthma. Serum
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …
levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We …